Evidence map›Paper›PMID 37241221›Full record

ArticleMedicina (Kaunas, Lithuania)2023

Higher Expression Levels of

Turki M Alrubie, Abdullah M Alamri, Bader O Almutairi, Abdulwahed F Alrefaei, Maha M Arafah, Mohammad Alanazi, Abdelhabib Semlali, Mikhlid H Almutairi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. IncreasedPharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Turki M AlrubieZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Abdullah M AlamriGenome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 11495, Saudi Arabia.
Bader O AlmutairiZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-4697-5204
Abdulwahed F AlrefaeiZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-3761-6656
Maha M ArafahPathology Department, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
Mohammad AlanaziGenome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 11495, Saudi Arabia.
Abdelhabib SemlaliGroupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire, Université Laval, 2420 Rue de la Terrasse, Local 1758, Québec, QC G1V 0A6, Canada.ORCID 0000-0002-5797-8304
Mikhlid H AlmutairiZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-0337-6412
King Saud University · SAUniversité Laval · CA

Funding

This work was funded by the National Plan for Science, Technology and Innovation (MAARIFAH), King Abdul-Aziz City for Science and Technology, Kingdom of Saudi Arabia, 2-17-01-001-0069
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colonic NeoplasmsTesticular NeoplasmsBiomarkers, TumorDecitabineHistonesHumansMaleMethylationOncogene Proteins, FusionPolymerase Chain ReactionBiomarkers, TumorDecitabineHistonesOncogene Proteins, Fusion5-aza-2′-deoxycytidinecolon cancerexpressionSSX1SSX2SSX3trichostatin

Identifiers

PMID37241221
PMCPMC10224331
OpenAlexW4377290634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.